Treatment of infections caused by clarithromycin sensitive microorganisms:
Upper respiratory tract infections, ie nasopharynx (tonsillitis, pharyngitis), and infections of the paranasal sinuses.
Lower respiratory tract infections (bronchitis, acute croupous pneumonia and primary atypical pneumonia).
Skin and soft tissue infections (impetigo, folliculitis, erysipeloid, boils, infected wounds).
Acute and chronic odontogenic infections.
Disseminated or localized mycobacterial infections caused by Mycobacterium avium or Mycobacterium intracellulare. Localized infections caused by Mycobacterium chelonae, Mycobacterium fortuitum or Mycobacterium kansasi.
Eradication of H. pylori in patients with duodenal ulcer with inhibition of hydrochloric acid secretion (clarithromycin activity against H. pylori at neutral pH is higher than at acidic pH).